Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?

Do Young Kim; Kwang Hyub Han

doi:10.1111/j.1440-1746.2011.06901.x

Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?

Department of Internal Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1585-1586
Number of pages	2
Journal	Journal of Gastroenterology and Hepatology (Australia)
Volume	26
Issue number	11
DOIs	https://doi.org/10.1111/j.1440-1746.2011.06901.x
Publication status	Published - 2011 Nov

All Science Journal Classification (ASJC) codes

Hepatology
Gastroenterology

Access to Document

10.1111/j.1440-1746.2011.06901.x

Cite this

@article{74981a624e734138a92b2ae5008f2e15,

title = "Sorafenib, doesn't it have any competitor in advanced hepatocellular carcinoma?",

author = "Kim, {Do Young} and Han, {Kwang Hyub}",

year = "2011",

month = nov,

doi = "10.1111/j.1440-1746.2011.06901.x",

language = "English",

volume = "26",

pages = "1585--1586",

journal = "Journal of Gastroenterology and Hepatology (Australia)",

issn = "0815-9319",